# MEA Colorectal Cancer Market > Middle-East and Africa Colorectal Cancer Market Research Report Information, by Type (Adenocarcinomas, Carcinoid Tumors, Gastrointestinal Stromal Tumors (GISTs), Lymphomas, Sarcomas), Diagnosis (Faecal Occult Blood Test, Colonoscopy, Virtual Colonoscopy, Stool DNA Test, Digital Rectal Examination, Flexible Sigmoidoscopy, Biopsy, Magnetic resonance Imaging (MRI) and Others), Treatment Type (Surgery, Radiation Therapy, Chemotherapy, Targeted Drug Therapy and others) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 7.43% - **2024:** $ 1,250 Million - **2032:** $ 2.43 Billion - **2035:** $ 2,750 Million - **Key Players:** Apple Inc (US), Microsoft Corp (US), Amazon.com Inc (US), Alphabet Inc (US), Berkshire Hathaway Inc (US), Tesla Inc (US), Meta Platforms Inc (US), Johnson & Johnson (US), Visa Inc (US), Procter & Gamble Co (US) **Report ID:** MRFR/MED/1911-HCR · **Pages:** 80 · **Author:** Vikita Thakur & Kinjoll Dey · **Last Updated:** June 26, 2026 **URL:** https://www.marketresearchfuture.com/reports/mea-colorectal-cancer-market-2551 --- ## Market Summary ## **Middle-East and Africa Colorectal Cancer Market Overview** The MEA Colorectal Cancer Market Size was valued at USD 1.90 Billion in 2023. The MEA Colorectal Cancer industry is projected to grow from USD 2.10 Billion in 2024 to USD 2.43 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.11% during the forecast period (2024 - 2032). The colon and rectum belong to our body's digestive system - together they are also known as the large bowel.  Colorectal cancer is cancer that starts in the colon or rectum. Colorectal cancer (CRC), also known as bowel cancer and colon cancer. The colon absorbs water and nutrients from the food and stores waste matter (stool). Stool moves from the colon into the rectum before it leaves the body. Each year, around 5,000 Saudis are diagnosed with having cancer, such as colon cancer and breast cancer. Middle East and Africa Colorectal Cancer market is growing steadily. **In February 2024** by Exact Sciences Corporation that they are preparing to launch a new suite of tests over the coming years, including an updated version of their proven stool-based colorectal cancer screening test, Cologuard; a complementary blood-based assay and a minimal residual disease detection assay. Guardant Health submitted Shield blood test application for premarketing approval to the FDA in May 2023. **In April 2023**, Mainz Biomed disclosed its collaboration with the Instituto de Microecologia aimed at expanding ColoAlert into Spain and Portugal. The device designed specifically for lower bowel inspection—CF-HQ1100DL/I colon videoscope has been launched by Olympus corporation. It includes anus, rectum, sigmoid colon, colon and ileocecal valve areas. This premiere would make possible broader range of products available within Olympus’ portfolio in field of colorectal cancer screening and diagnostics. Japan's Akeda has partnered with Hutch med from Hong Kong to get commercial rights outside China for fruquintinib, which is used as a drug against colon cancer (CRC). A study combining Cotellic targeted therapy and immuno-oncologic agents for CRC treatment is being conducted by Roche scientists. Bio-Rad Laboratories Inc.’s acquisition process of Curiosity Diagnostics Poland, based medical diagnostic innovative technology provider, ended in August 2022. The merger enabled Bio-Rad to increase its product pipeline as well as extend its presence across Middle East Africa marketplaces. New applications have been announced by QIAGEN for QI Acuity, its ultrasensitive digital PCR (dPCR) platform, in January 2022, which is expected to revolutionize the field by utilizing “nanoplates” to process samples in two hours instead of five. In turn, it has enlarged several products offered by the firm as well as expanded its overall revenues. ## **Middle-East and Africa Colorectal Cancer Market Segment Insights** ### **Middle-East and Africa Colorectal Cancer Type Insights** Middle-East and Africa Colorectal Cancer market has been segmented on the basis of type which Adenocarcinomas, Carcinoid tumors, Gastrointestinal stromal tumors (GISTs), Lymphomas, Sarcomas, and others. ### **Middle-East and Africa Colorectal Cancer Diagnosis Insights** On the basis of diagnosis the market is segmented into Faecal Occult Blood Test, Colonoscopy, Virtual Colonoscopy, Stool DNA test, Digital Rectal Examination, Flexible Sigmoidoscopy, Biopsy, Magnetic resonance imaging (MRI), and Others. ### **Middle-East and Africa Colorectal Cancer Treatment Insights** On the basis of treatment type market is segmented into Surgery, Radiation Therapy, [Chemotherapy](../../../reports/chemotherapy-market-5791), targeted drug therapy, and others. ### **Middle-East and Africa Colorectal Cancer Regional Insights** Considering the Middle East and Africa Colorectal Cancer Market scenario, UAE region is believed to be the largest market for Middle East and Africa Colorectal Cancer. Moreover, Saudi Arabia market is also growing and second largest market for patient monitoring devices. On the other hand, Egypt market is expected to grow at the steady pace in the Middle East and Africa Colorectal Cancer during the forecasted period. Rest of the Middle East and Africa region is likely to have a limited but steady growth in the market. The report for Middle East and Africa Colorectal Cancer Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different market’s segments and regions **Key Players for Middle-East and Africa Colorectal Cancer Market** Some of the key players in this market are: **Study Objectives of Middle-East and Africa Colorectal Cancer Market** **Intended Audience** ## Market Drivers ### Market Growth Projections The Global Middle-East and Africa Colorectal Cancer Market Industry is expected to experience substantial growth, with projections indicating a market size of 1250 USD Million in 2024 and an anticipated increase to 2750 USD Million by 2035. This growth trajectory suggests a compound annual growth rate of 7.43% from 2025 to 2035, reflecting the increasing demand for [colorectal cancer screening](https://www.marketresearchfuture.com/reports/colorectal-cancer-screening-market-9203), diagnosis, and treatment options. The market dynamics are influenced by various factors, including rising incidence rates, advancements in medical technology, and enhanced healthcare expenditure. ### Rising Geriatric Population The aging population in the Middle-East and Africa is a significant driver of the Global Middle-East and Africa Colorectal Cancer Market Industry. As individuals age, the risk of developing colorectal cancer increases, leading to a higher demand for screening and treatment services. This demographic shift is prompting healthcare providers to adapt their services to meet the needs of older patients. Consequently, the market is poised for growth, with projections indicating a rise to 1250 USD Million in 2024. Addressing the healthcare needs of this population will be crucial for improving cancer care in the region. ### Growing Healthcare Expenditure The increase in healthcare expenditure across the Middle-East and Africa is fostering growth in the Global Middle-East and Africa Colorectal Cancer Market Industry. Governments are allocating more resources to cancer care, which includes funding for research, treatment facilities, and patient support services. This trend is likely to enhance the availability of advanced treatment options, thereby improving patient outcomes. As healthcare budgets expand, the market is expected to benefit from increased investment in colorectal cancer management, contributing to its projected growth to 2750 USD Million by 2035. ### Rising Incidence of Colorectal Cancer The Global Middle-East and Africa Colorectal Cancer Market Industry is witnessing a notable increase in the incidence of colorectal cancer, attributed to lifestyle changes and dietary habits. Reports indicate that colorectal cancer is among the most prevalent cancers in the region, with a rising number of cases each year. This trend is likely to drive demand for screening and treatment options, as healthcare systems strive to address the growing burden. The market is projected to reach 1250 USD Million in 2024, reflecting the urgent need for effective interventions and resources to manage this escalating health concern. ### Advancements in Diagnostic Technologies Innovations in diagnostic technologies are significantly impacting the Global Middle-East and Africa Colorectal Cancer Market Industry. Enhanced imaging techniques and genetic testing are improving early detection rates, which is crucial for effective treatment. For instance, the introduction of non-invasive screening methods has made it easier for healthcare providers to identify at-risk populations. As awareness of these technologies grows, more patients are likely to seek screening, thereby expanding the market. The anticipated growth in this sector is expected to contribute to the market's expansion, potentially reaching 2750 USD Million by 2035. ### Government Initiatives and Awareness Campaigns Government initiatives aimed at increasing awareness about colorectal cancer are playing a pivotal role in shaping the Global Middle-East and Africa Colorectal Cancer Market Industry. Various health ministries are launching campaigns to educate the public about risk factors and the importance of early detection. These efforts are likely to encourage more individuals to participate in screening programs, thereby increasing the overall market size. As a result, the market is expected to grow at a compound annual growth rate of 7.43% from 2025 to 2035, reflecting the positive impact of these initiatives on public health. ## Future Outlook The Middle-East and Africa Colorectal Cancer Market is projected to grow at a 7.43% CAGR from 2025 to 2035, driven by rising incidence rates, advancements in screening technologies, and increased healthcare expenditure. **New opportunities:** - Develop targeted therapies to address genetic variations in colorectal cancer. Invest in telemedicine platforms for [remote patient monitoring](https://www.marketresearchfuture.com/reports/remote-patient-monitoring-market-10905) and consultations. Expand access to early screening programs in underserved regions. By 2035, the market is expected to exhibit robust growth, reflecting enhanced treatment options and improved patient outcomes. ## Segment Insights ### Middle-East and Africa Colorectal Cancer Market Segment Insights ### Middle-East and Africa Colorectal Cancer Type Insights Middle-East and Africa Colorectal Cancer market has been segmented on the basis of type which Adenocarcinomas, Carcinoid tumors, [Gastrointestinal stromal tumors](https://www.marketresearchfuture.com/reports/gastrointestinal-stromal-tumors-market-1583) (GISTs), Lymphomas, Sarcomas, and others. ### Middle-East and Africa Colorectal Cancer Diagnosis Insights On the basis of diagnosis the market is segmented into Faecal Occult Blood Test, Colonoscopy, Virtual Colonoscopy, Stool DNA test, Digital Rectal Examination, Flexible Sigmoidoscopy, Biopsy, Magnetic resonance imaging (MRI), and Others. ### Middle-East and Africa Colorectal Cancer Treatment Insights On the basis of treatment type market is segmented into Surgery, Radiation Therapy, Chemotherapy, targeted drug therapy, and others. ## Report Scope | Attribute/Metric | Details | | --- | --- | |   Market Size 2032 |   USD 2.43 Billion | |   CAGR |   6.11% (2024 -2032) | |   Base Year |   2023 | |   Forecast Period |   2024 -2032 | |   Historical Data |   2020 | |   Forecast Units |   Value (USD Billion) | |   Report Coverage |   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | |   Segments Covered |   Type, Diagnosis and Treatment Type | |   Geographies Covered |   UAE, Saudi Arabia, Egypt | |   Key Vendors |   F. Hoffmann-La Roche Ltd (Switzerland), Amgen Inc. (US), Novartis AG(Switzerland), Abbott (US), Beckman Coulter Inc. (US), Debiopharm Group (Switzerland), AbbVie Inc. (US), Bayer AG (Germany) | |   Key Market Opportunities |   Joint ventures, strategic alliances, mergers and acquisitions, new product developments | |   Key Market Drivers |   technological advancement, macro economical and governing factors | --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/mea-colorectal-cancer-market-2551*